Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services
Celerion Expands Early Phase Clinical Pharmacology Units
read more
CLEANROOM NEWS FEATURE Articles
CARsgen Therapeutics launches 37,000-ft cleanroom facility for clinical and early-stage commercial manufacturing
CARsgen Therapeutics 37,000-ft facility for clinical and early-stage commercial manufacturing was designed and built in just 12 months.
On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility
The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency
N2 Biomedical Announces The First Surgical Implant Of A Spinal Device Coated With The Company’s Thin, Ion-Assisted Titanium Coating Technology
N2 is ISO-13485 certified, FDA GMP-compliant, and operates in a 30,000 square foot facility with cleanroom, laboratory, manufacturing, and cleanroom space to service all customer and regulatory requirements. The company leverages its proprietary processes and equipment to provide customized solutions
Heska Corporation to Acquire Lacuna Diagnostics, a Pioneer and Market Leader in Point-of-Care Digital Cytology
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the “Agreement”) to acquire 100% of Lacuna Diagnostics, Inc. (“Lacuna”), a pioneer and market leader in point-of-care diagnostics digital cytology technology and telemedicine services.
Nova to Expand Offices in Taiwan with New Cleanroom and Training Center
Nova celebrated today Nova Taiwan’s 20th anniversary with the opening of its new, expanded cleanroom facilities in Taiwan as part of the Company’s strategy to strengthen field operations and local training.
AirBox Air Purifier Scientifically Proven to Remove >99.99% of Airborne Pathogens, Including MS2 Bacteriophage, a SARS-Cov-2 (COVID-19) Representative Virus
At a time when a clean and safe air environment is of paramount importance for school systems and businesses, certified HEPA AirBox Air Purifier Peak Series-S has been scientifically proven by independent lab testing company Microchem Laboratory to filter 99.99% of MS2 Bacteriophage, a SARS-Cov-2 (COVID-19) representative virus, and three other common pathogens in just 25 minutes, achieving a 4 log reduction of particulates.
ASGARD Partners & Co. Acquires Angstrom Technology
ASGARD Partners & Co., a New York-based private equity firm, today announced an agreement to acquire a controlling interest in Angstrom Technology
Prime Minister announces £20m to grow medicines manufacturing in the UK
The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.
NoviSphere™ Launches Pathogen-Eradication System
NoviSphere™, a developer of comprehensive rarified-environment solutions officially launched today. Using scientifically proven short-wavelength ultraviolet (UV-C) pathogen-eradication systems and additional cleanroom technologies, NoviSphere delivers ultraclean, protected environments that promote health and safety, allowing people to get back to business, back to work and back to life.
Essentium Introduces Industry-First Anti-Static Material To Advance Additive Manufacturing Applications In The Aerospace And Defense Industries
Essentium Introduces Industry-First Anti-Static Material To Advance Additive Manufacturing Applications In The Aerospace And Defense Industries
Purolite Announces Expansion to Address the High-demand for Pharmaceutical Products
Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products. The new facility will include two new cleanrooms to manufacture active pharmaceutical ingredients (APIs) and excipients and an agarose manufacturing facility equipped with proprietary jetting technology for the capture and purification of (mAbs) monoclonal antibodies sold under the Praesto® brand.